EACR-19

 

19th MEETING OF THE EUROPEAN ASSOCIATION FOR CANCER RESEARCH
The Best of Cancer Research in Europe

Budapest, Hungary - 1 - 4 July 2006

N E W S F L A S H

ABSTRACT DEADLINE 10 March 2006

Deadline payment for early rate registration: 3 February 2006


With now more than 5000 members, EACR has become the largest European organisation exclusively focused on Cancer Research. The EACR Meeting has developed as the pivotal European forum for basic scientists, translational researchers and clinical oncologists alike.

 
The advance programme and further information is available on www.fecs.be

As you will see, the meeting will cover the most important recent advances and developments in experimental oncology and corresponding translational research, so don't miss this important event!

Abstracts for short oral or poster presentations from all areas of Cancer Research are welcomed.

Members of the Magyar Onkologusok Tarsasaga (MOT, www.oncology.hu) may apply for MOT-Award to cover Registration Fees. Applications should be sent before 10 March 2006 to the E-mail: garami@oncol.hu or to the fax (1) 224-8741. Preference will be given to those actively participating in the meeting or/and to younger members of the MOT. Further consultation is possible at E-mail: evaillyes@oncol.hu

Registration fees

 

Early rate:

Payment received

before

3 February 2006

Late rate:

Payment received

before

16  June 2006

 

Desk rate:

 

On-site only

 

Day rate:

 

On-site only

 

Members EACR/ MOT*

 

Non-members

 

 

275 EUR

 

350 EUR

 

330 EUR

 

430 EUR

 

400 EUR

 

500 EUR

 

 

175 EUR

 

175 EUR

 

Student

Members EACR MOT*

 

 

 

115 EUR

 

 

115 EUR

 

 

115 EUR

 

 

175 EUR

 

Student

Non-members*

 

 

 

175 EUR

 

 

175 EUR

 

 

175 EUR

 

 

175 EUR

 

*Under 30 years. Please send a letter from your head of department to-confirm your student status

 

 

Plenary lectures by:
J Baselga (ES), R Bernards (NL), P Boyle (FR), J W Gray (US), W G Kaelin, Jr (US), R Laskey (UK), K Vousden (UK).

Confirmed speakers:
R Aasland (NO), K Alitalo (FI), A Bardelli (IT), A Brehm (DE), P J Brennan (FR), P Boffetta (FR), A L Borresen-Dale (NO), V Castronovo (BE), M F Clarke (US), H Clevers (NL), M P Colombo (IT), L M Coussens (US), P B Dirks (CA), D Goldgar (US), M N Hall (CH), R D Hannan (AU), P A Jones (US), O Kallioniemi (FI), E C Kohn (US), J C Lacal (ES), R Marais (UK), G B Mills (US), A J Minn (US), M Naumann (DE), E Pikarsky (IL), M Smalley (UK), M R Stratton (UK), A Teti (IT), R Waters (UK), R J White (UK), P Workman (UK)

Educational Lectures:
C Belka (DE), A Brazma (UK), P Friedl (DE), M Smales (UK), T Sorlie (NO), Y Yarden (IL)

 

Highlight Sessions

 

Saturday 1 July 2006

  • The control of DNA replication and its exploitation for cancer diagnosis or treatment
  • Cancer cell growth
  • Genetics and the environment

 

Sunday 2 July 2006

  • Signal transduction network
  • Gene expression profiling
  • Europe against cancer
  • Molecular determinants of site specific metastasis
  • Canceromics
  • Angiogenesis

 

Monday 3 July 2006

  • Proteomics and mass spectrometry
  • Radiation oncology
  • P53 and cancer
  • Experimental therapeutics
  • Cancer stem cells
  • Inflammation and cancer
  • Cancer epigenetics
  • Identification of cancer relevant genes using functional genetic approaches

 

Tuesday 4 July 2006

  • Dynamic imaging of cell invasion in vitro an in vivo
  • Bioinformatics
  • Systems biology
  • Targeted therapy